 | Up a level |
2020
Barnert, A., Kunze, A., Scheid, C., Liekweg, A., Hermes-Moll, K. and Jaehde, U. (2020). Extended medication plan for patients with ORal tumortherapy (EMPORT). Int. J. Clin. Phar,., 42 (1). S. 234 - 236. DORDRECHT: SPRINGER. ISSN 2210-7711
2018
Lenssen, R., Schmitz, K., Griesel, C., Heidenreich, A., Schulz, J. B., Trautwein, C., Marx, N., Fitzner, C., Jaehde, U. and Eisert, A. (2018). Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial. BMC Geriatr., 18. LONDON: BIOMED CENTRAL LTD. ISSN 1471-2318
2016
Suleiman, A. A., Schoettle, J., Jaehde, U., Ullrich, R. and Fuhr, U. (2016). High-pulsed doses of erlotinib for the treatment of non-small-cell lung cancer: A modeling analysis. Naunyn-Schmiedebergs Arch. Pharmacol., 389 (1). S. S70 - 2. NEW YORK: SPRINGER. ISSN 1432-1912
2014
Wilmer, A., Tasar, A., Fleckenstein, K., Hack, C., Beck, H., Liekweg, A., Ruberg, K., Ko, Y. D. and Jaehde, U. (2014). Evaluation of a best-practice model for multiprofessional cancer medication management. Oncol. Res. Treat., 37. S. 103 - 105. BASEL: KARGER. ISSN 2296-5262
2010
Abduljalil, K., Frank, D., Gaedigk, A., Klaassen, T., Tomalik-Scharte, D., Jetter, A., Jaehde, U., Kirchheiner, J. and Fuhr, U. (2010). Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan. Clin. Pharmacol. Ther., 88 (5). S. 643 - 652. NEW YORK: NATURE PUBLISHING GROUP. ISSN 0009-9236